Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
A SQUARE

Expertise on Private Investments in Public Equities (PIPEs)

Tuesday, March 20, 2007
Mitch Hull separates the facts from the fiction in this promising space.

A SQUARE :: 20Mar07 Expertise on Private Investments in Public Equities (PIPEs)
Category PIPEs
Faculty Mitch Hull
Expertise Private investments in public equities (PIPES)
Author Sona Blessing
Faculty Name
Mitch Hull has over a decade of experience, is founder of Hull Capital Management, LLC, and shares his insights on private investments in public equities (PIPEs)...


“In a PIPE offering there are less regulatory issues with the SEC” ... then why is investing in them perceived with such notoriety?


The “notoriety” in a PIPE transaction is really a function of historical biases created in the early days of
PIPE investing. In the mid to late 90’s PIPEs, known at the time as Reg. D Private Placements, were new
to the capital markets and the dominant transaction structure was the floorless floating convertible bond.


It was embraced by a vast majority (at present it constitutes 5% of the market). This structure is known more pejoratively as the “toxic convertible” or “death spiral” as a number of dot com companies that had used this structure experienced negative outcomes when the Internet “bubble burst”. Many of those issuers’business models proved to be failures – and some erroneously continue to blame the PIPE structure for the same.

Today, very few transactions are completed with floating conversion features.

Download this research The many benefits of an A SQUARE subscription Recommend to a friend

<< A SQUARE archive sorted by date    << A SQUARE archive sorted by category

 Article link
More research related to PIPEs

[04Jun09] [PIPEs] Invests directly through private placements in growth companies ...
As active private placement investors in the industry have established a robust deal flow network

Download

[21May09] [Warrants/PIPEs] A fund that holds warrants (issued in PIPE deals)
Steadily increasing size of deals indicate a demand for PIPE transactions

Download

[07May08] [PIPEs] PIPE Opportunities in China
Geography is still a challenge with China but it is mitigated in part because the companies trade in the US.

Download

[24Oct07] [PIPEs] Private investments in public equities FOF
With SEC regulatory changes, PIPE deal flow will increase - the strategy is increasingly being deployed outside the US, particularly in Europe and Asia.

Download

[02May07] [PIPEs] PipeLine Investors, LP
In 2005 Mar Hedge ranked PipeLine Investors in the Top 10 Performing Risk Adjusted Funds of Funds in the U.S.

Download
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its